Security Snapshot

PROKIDNEY CORP. - Class A Common Stock (PROK) Institutional Ownership

CUSIP: 74291D104

13F Institutional Holders and Ownership History from Q2 2025 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

62

Shares (Excl. Options)

42.8MFull value: 42,799,869 · shares · 30 Sep 2026

Price

$1.66

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+2,904,055
Value change
+$4,762,797
Number of holders
62
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
205,399,064
SEC-reported price per share
$1.47
Insider filing price
$1.47
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • PROK - PROKIDNEY CORP. - Class A Common Stock is tracked under CUSIP 74291D104.
  • 62 institutions reported positions in Q3 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 71 to 62 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $97.72MFull value: $97,719,950 · USD · 30 Jun 2026
    to
    $71.05MFull value: $71,048,923 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 62 institutions filings for Q3 2026.

Open SEC evidence

Security key

74291D104

13F reference period

Q3 2026

13F holders

62

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
PROK
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Control Empresarial de Capitales S.A. de C.V. 36% $132,052,942 73,842,723 Control Empresarial de Capitales S.A. de C.V. 28 Apr 2026
MORGAN STANLEY 4.7% -22% $15,542,547 +$1,825,376 9,653,756 +13% Morgan Stanley 30 Jun 2026
As of 30 Sep 2026, 62 institutional investors reported holding
42.8MFull value: 42,799,869 · shares · 30 Sep 2026
shares of PROKIDNEY CORP. - Class A Common Stock (PROK). This represents 21% of the company’s total
205.4MFull value: 205,399,064 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
15%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MONTANOVA CAPITAL, LLC 6% 12,341,266 0.56% $20,486,502
GEODE CAPITAL MANAGEMENT, LLC 1.7% 3,590,979 0% $5,962,117
Propel Bio Management, LLC 0.98% 2,009,733 1.9% $3,336,157
Bleichroeder LP 0.93% 1,900,000 0.31% $3,154,000
STATE STREET CORP 0.88% 1,810,345 0% $3,005,173
Hennion & Walsh Asset Management, Inc. 0.88% 1,806,553 0.09% $2,998,878
VANGUARD CAPITAL MANAGEMENT LLC 0.84% 1,726,762 0% $2,866,425
VANGUARD FIDUCIARY TRUST CO 0.48% 982,525 0% $1,630,992
VANGUARD PORTFOLIO MANAGEMENT LLC 0.37% 761,533 0% $1,264,145
BANK OF AMERICA CORP /DE/ 0.27% 560,009 0% $929,615
Artia Global Partners LP 0.27% 553,744 0.19% $919,215
Simplify Asset Management Inc. 0.24% 483,741 0.01% $803,010
TWO SIGMA INVESTMENTS, LP 0.18% 362,705 0% $602,090
GSA CAPITAL PARTNERS LLP 0.14% 295,166 0.03% $490,000
Cerity Partners LLC 0.14% 284,022 0% $471,476
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.11% 225,790 0% $374,811
Voleon Capital Management LP 0.1% 210,077 0.01% $348,728
Carolina Financial Advisors, Inc 0.09% 182,636 0.19% $303,175
GOLDMAN SACHS GROUP INC 0.08% 171,934 0% $285,410
Quadrature Capital Ltd 0.04% 74,186 0% $123,149
MetLife Investment Management, LLC 0.03% 67,147 0% $111,464
Vanguard Global Advisers, LLC 0.03% 60,477 0% $100,392
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.03% 52,307 0% $86,830
NEW YORK STATE COMMON RETIREMENT FUND 0.02% 45,600 0% $75,696
Invesco Ltd. 0.02% 45,503 0% $75,535

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
6
Headline period
Q3 2026
Rows shown
1-6 of 6
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 42,799,869 $71,048,923 +$4,762,797 $1.66 62
2026 Q2 47,907,242 $97,719,950 +$11,014,270 $2.04 71
2026 Q1 42,655,656 $76,353,029 +$964,134 $1.79 69
2025 Q4 41,945,569 $93,958,103 +$18,974,610 $2.24 62
2025 Q3 33,452,097 $80,954,450 +$79,786,213 $2.42 55
2025 Q2 527,620 $311,428 +$311,428 $0.59 5
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .